Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma

Published:2012-06-26 Issue:1 Volume:119 Page:136-142
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lee Joo Ho,Chung Young-Hwa,Kim Jeong A.,Shim Ju Hyun,Lee Danbi,Lee Han Chu,Shin Eun-Soon,Yoon Jung Hwan,Kim Byung Ik,Bae Si Hyun,Koh Kwang Cheol,Park Neung-Hwa

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a hepatitis B virus-endemic area;Shim;J Cancer Res Clin Oncol.,2009

2. Prognosis of hepatocellular carcinoma;Llovet;Hepatogastroenterology.,2002

3. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet.,2002

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med.,2008

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer: A Prospective, Randomized, Multicenter, Phase II Study;Oncology Research and Treatment;2024-07-19

2. A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Topical Urea for Secondary Prophylaxis of Hand Foot Skin Reaction in Renal Cell Cancer Patients on Sunitinib Therapy;Clinical Genitourinary Cancer;2024-06

3. Practicality of STAT3 Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma;Journal of Clinical Pharmacy and Therapeutics;2023-08-19

4. Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose;European Journal of Cancer;2023-06

5. Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/ KEYNOTE ‐775;Cancer Science;2022-07-26